EPTIS
BAM Logo

Virus Detection (Genome/Antigen) – Influenza A and B Viruses incl. Avian Influenza A Viruses

[Virus-Nachweis (Genom/Antigen) – Influenza A- und B-Viren inkl. aviäre Influenza A-Viren]

EPTIS factsheet 159532 | Last revision 2017-10-26 | URL: https://www.eptis.bam.de/pts159532 https://www.eptis.bam.de/pts159532

PT provider
PT provider INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
Based in Germany
Language(s) German, English
Remarks This program may be completed with currently circulating influenza viruses. Please note: these EQA samples are not suitable for virus propagation and immune fluorescence tests for antigen detection. Some of the samples can contain chemically inactivated avian influenza A viruses. Please fill in page 2 of the order form for handling of infectious samples for EQAS unless you already returned your completed form 2 to INSTAND e. V. when you registered for recent EQA schemes. Without your confirmation we cannot send you the EQAS samples. The INSTAND EQA schemes in virology are carried out in scientific cooperation with the Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten (DVV e.V.), Gesellschaft für Virologie (GfV e.V.) and Deutsche Gesellschaft für Hygiene und Mikrobiologie (DGHM e.V.). The characterization of the EQA samples including the determination of the target values/consensus values is carried out in cooperation with the INSTAND Expert laboratories. Cooperation with: Nationales Referenzzentrum für Influenza, Robert Koch-Institut, Berlin; Friedrich-Loeffler-Institut, Bundesforschungsinstitut für Tiergesundheit, Nationales Referenzlabor für Aviäre Influenza, Insel Riems Information for 2018 (for details please see www.instand-ev.de -> EQAS and EQAS Online)
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Lyophilized cell culture-lysates and allantoic fluids, respectively Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for influenza A and B viruses and antigen testing -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants 250 - 500
Accredited or otherwise reviewed by a 3rd party

Accredited by DAkkS (Germany) on the basis of ISO/IEC 17043

Operation is commissioned / requested by German Bundesärztekammer (General medical Council)
Fees and frequency
Participation fee 240 Euro
Regularly operated Yes (2 times per year)
Year of first operation Experience with operation of ILCs since 1968
Contact details of the PT provider
Provider Contact person
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
P.O.Box 250211, Ubierstrasse 20
40223 Düsseldorf
Germany

Phone: +49-211-159213-0
Fax: +49-211-159213-30
Web: http://www.instandev.de/ http://www.instandev.de/
Dr. rer. nat. Nathalie Wojtalewicz
Phone: +49-211-15921341
Fax: +49-211-15921330
Email: wojtalewicz@instand-ev.de wojtalewicz@instand-ev.de
If you find any mistakes please contact the responsible EPTIS coordinator in Germany, Mr Johannes van de Kreeke. Mr Johannes van de Kreeke.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21